The expression of fibroblast growth factor receptor-3 in synovial osteochondromatosis of the temporomandibular joint

Archives of Oral Biology

Volumn 49, Issue 7, 2004, Pages 591-594

  Tojyo, Itaru ^a   Yamaguti, Akihiko ^a   Ozaki, Harumi ^a   Yoshida, Hiroaki ^a   Fujita, Shigeyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Fibroblast growth factor receptor 3; Immunohistochemistry; Reverse transcription polymerase chain reaction; Synovial osteochondromatosis; Temporomandibular joint

Indexed keywords

FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; CELL CULTURE; CHONDROMATOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; CELLS, CULTURED; CHONDROMATOSIS, SYNOVIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTORS, FIBROBLAST GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNOVIAL MEMBRANE; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 2342468748     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2003.12.009     Document Type: Article

References (14)

1. Milgram J.W. Synovial osteochondromatosis. J. Bone Joint Surg. 59A:1977;792-801
2. Villacin A.B., Brigham L.N., Bullough P.G. Primary and secondary synovial chondrometaplasia. Hum. Pathol. 10:1979;439-451
3. Robinson D., Hasharoni A., Evron Z., Segal M., Nevo Z. Synovial chondromatosis: the possible role of FGF9 and FGF receptor 3 in its pathology. Int. J. Exp. Pathol. 81:2000;183-189
4. De Bari C., Dell'Accio F., Tylzanowski P., Luyten F.P. Multiponent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44:2001;1928-1942
5. Robinson D., Hasharoni A., Cohen N., Yayon A., Moskowitz R.M., Nevo Z. Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. Clin. Orthop. 367S:1999;S163-S175
6. Robinson D., Hasharoni A., Yayon A., Oganesian A., Nevo Z. Role of FGF9 and FGF receptor 3 in osteochondroma formation. Orthopedics. 24:2001;783-787
7. Naski M.C., Colvin J.S., Coffin J.D., Orinitz D.M. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development. 125:1998;4977-4988
8. Rousseau F., Bonaventure J., Legeal-Mallet L., et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371:1994;252-254
9. Bellus G.A., McIntosh I., Smith E.A., et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10:1995;357-359
10. Tavormina P.L., Rimoin D.L., Cohn D.H., et al. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type? Hum. Mol. Genet. 4:1995;2175-2177
11. Tavormina P.L., Shiang R., Thompson L.M., et al. Thanatophoric dysplasia (type I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9:1995;321-328
12. Su W.S., Kitagawa M., Xue N., et al. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 386:1997;288-292
13. Sahni M., Ambrosetti D.C., Mansukhani A., Gertner R., Levy D., Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13:1999;1361-1366
14. Rozenblatt-Rosen O., Mosonego-Ornan E., Sadot E., et al. Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J. Cell. Sci. 115:2002;553-562